Search research articles
Contact Us
Filters
Showing results (231-240 of 342) with videos related to
Page
of 35
Sort By:
Cancer Research
|
February 1, 1992
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule
P C Adamson, F M Balis, J Miser, et al.
The Pediatric Infectious Disease Journal
|
July 14, 2009
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants
Kelly C Wade, Daniel K Benjamin, David A Kaufman, et al.
Pediatric Blood & Cancer
|
August 20, 2013
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group
Brenda Weigel, Suman Malempati, Joel M Reid, et al.
Cancer Chemotherapy and Pharmacology
|
December 20, 2011
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study
Steven G DuBois, Suzanne Shusterman, Joel M Reid, et al.
Journal of Clinical Microbiology
|
January 9, 2003
Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs
J R Uhl, S C Adamson, E A Vetter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer
G T Budd, P C Adamson, M Gupta, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 19, 1999
Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine
B J Kitchen, A Moser, E Lowe, et al.
Pediatric Blood & Cancer
|
January 6, 2010
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study
Lars M Wagner, John P Perentesis, Joel M Reid, et al.
Cancer
|
January 27, 2009
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study
Lisa M McGregor, Sheri L Spunt, Wayne L Furman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2026
PenA Alleles Associated With Gonococcal Ceftriaxone Resistance in Cambodia, China, and Vietnam
Stijn van der Veen, Xia Sun, Haoyu Ge, et al.
Page
of 35
Search research articles
Search
Showing results (231-240 of 342) with videos related to
Sort By:
Page
of 35
Cancer Research
|
February 1, 1992
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule
P C Adamson, F M Balis, J Miser, et al.
The Pediatric Infectious Disease Journal
|
July 14, 2009
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants
Kelly C Wade, Daniel K Benjamin, David A Kaufman, et al.
Pediatric Blood & Cancer
|
August 20, 2013
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group
Brenda Weigel, Suman Malempati, Joel M Reid, et al.
Cancer Chemotherapy and Pharmacology
|
December 20, 2011
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study
Steven G DuBois, Suzanne Shusterman, Joel M Reid, et al.
Journal of Clinical Microbiology
|
January 9, 2003
Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs
J R Uhl, S C Adamson, E A Vetter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer
G T Budd, P C Adamson, M Gupta, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 19, 1999
Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine
B J Kitchen, A Moser, E Lowe, et al.
Pediatric Blood & Cancer
|
January 6, 2010
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study
Lars M Wagner, John P Perentesis, Joel M Reid, et al.
Cancer
|
January 27, 2009
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study
Lisa M McGregor, Sheri L Spunt, Wayne L Furman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2026
PenA Alleles Associated With Gonococcal Ceftriaxone Resistance in Cambodia, China, and Vietnam
Stijn van der Veen, Xia Sun, Haoyu Ge, et al.
Page
of 35